The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
Fernando J. Barreyro, Silvia Holod, Paola V. Finocchietto, Alejandra M. Camino, Jorge B. Aquino, Alejandra Avagnina, María C. Carreras, Juan J. Poderoso, Gregory J. Gores
Dive into the research topics of 'The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis'. Together they form a unique fingerprint.